Friday, July 18, 2008

Baxter Q2 - Strong Floseal and Coseal results

Rob Davis said "Sales of regenerative medicine business totaled $109 million and increased 25%, with currency contributing 8 percentage points of growth. This continues to be the result of strong growth of FLOSEAL and COSEAL."
Full transcript HERE

No comments: